Data search
Results for MligTC455_14845
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_14845 | 166 | 3.46 | Mlig455_011437 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.201/0.00360 |
Mlig455_011437 {REF} {Length: 1014} {RNA1509_51062} {RNA1310_44466} {RNA815_28616} |
Cumulative graph for MligTC455_14845
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -3.462 | 2.56 | 0.99970 | 1.00000 | |
| RegionR2 | 4.201 | 2.56 | 0.00009 | 0.00360 | |
| RegionR3 | 2.878 | 2.56 | 0.00235 | 0.05597 | |
| RegionR4 | 1.344 | 2.56 | 0.30532 | 0.61850 | |
| RegionR5 | 0.769 | 2.56 | 0.47143 | 0.83417 | |
| RegionR6 | -1.013 | 2.56 | 0.93351 | 1.00000 | |
| RegionR7 | -0.186 | 2.56 | 0.81622 | 1.00000 | |
| RegionR8 | -4.532 | 2.56 | 0.99952 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -0.441 | 2.56 | 0.99995 | 1.00000 | |
| RegenerationR2 | -1.937 | 2.56 | 0.00434 | 0.10167 | |
| RegenerationR3 | -1.07 | 2.56 | 0.16690 | 0.60142 | |
| RegenerationR4 | 0.524 | 2.56 | 0.57924 | 0.90521 | |
| RegenerationR5 | -0.534 | 2.56 | 0.54431 | 0.88272 | |
| RegenerationR6 | 0.884 | 2.56 | 0.45591 | 0.77483 | |
| RegenerationBL | 2.039 | 2.56 | 0.25488 | 0.61197 | |
| RegenerationTP | 3.167 | 2.56 | 0.11752 | 0.52424 |
Genes with expression patterns similar to MligTC455_14845
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_14845 | 166 | 3.46 | Mlig455_011437 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.201/0.00360 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_011437 {REF} {Length: 1014} {RNA1509_51062} {RNA1310_44466} {RNA815_28616} | |
| 2. | MligTC455_15353 | 85 | 1.78 | Mlig455_015663, Mlig455_062473 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.265 Region-enriched R2: 9.386/0.02025 |
ARRB1 | 3.592 | 0.981 | - | 0.782 | 0.987 | 0.842 | - | Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1} Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1} |
| 3. | MligTC455_51806 | 83 | 1.73 | Mlig455_037702, Mlig455_046362 | Neo: - Age: - |
GPSM2 | 3.495 | - | 0.952 | 0.753 | 0.937 | 0.853 | - | Mlig455_037702 {REF} {Length: 3216} {Pfam: Tetratricopeptide repeat [PF13424.8, score=100.7]; Tetratricopeptide repeat [PF13176.8, score=98.7]; Tetratricopeptide repeat [PF00515.30, score=93.3]; GoLoco motif [PF02188.19, score=66.5]; Tetratricopeptide repeat [PF07719.19, score=54.7]; Tetratricopeptide repeat [PF13181.8, score=43.2]; Tetratricopeptide repeat [PF13374.8, score=34.5]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.8]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=521, Expect=3e-176]} {Mouse: ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=494, Expect=2e-166]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=534, Expect=0.0]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [Score=256, Expect=4e-76]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=462, Expect=3e-154]} {RNA1310_18538} {RNA815_41322} Mlig455_046362 {REF} {Length: 3324} {Pfam: Tetratricopeptide repeat [PF13424.8, score=119.4]; Tetratricopeptide repeat [PF13176.8, score=96.3]; Tetratricopeptide repeat [PF00515.30, score=93.0]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=54.4]; Tetratricopeptide repeat [PF13181.8, score=42.7]; Tetratricopeptide repeat [PF13374.8, score=34.2]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=21.7]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [Score=545, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=535, Expect=0.0]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=531, Expect=1e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=1e-79]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=474, Expect=1e-158]} {RNA1310_18538} {RNA815_41322} |
| 4. | MligTC455_25701 | 31 | 0.65 | Mlig455_017477 | Neo: - Age: - |
3.417 | - | 0.809 | 0.782 | 0.986 | 0.840 | - | Mlig455_017477 {REF} {Length: 664} {RNA1310_52753} {RNA815_26527} | |
| 5. | MligTC455_45999 | 128 | 2.67 | Mlig455_045216 | Neo: - Age: Down-Down-Up Region-enriched R2: 4.224/0.01692 |
3.353 | 0.808 | - | - | 0.977 | 0.767 | 0.801 | Mlig455_045216 {REF} {Length: 1119} {RNA1509_35312} {RNA1310_137994} {RNA815_42624} | |
| 6. | MligTC455_44954 | 1303 | 27.14 | Mlig455_029595, Mlig455_070648 | Neo: Int S/G2/M Age: Down-Up-Up, logFC(26M/2M)=1.023 Region-specific R2: 8.846 Region-enriched R2: 10.764/0.00000 |
3.317 | - | 0.740 | 0.730 | 0.987 | 0.860 | - | Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767} Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767} |
|
| 7. | MligTC455_08808 | 98 | 2.04 | Mlig455_029074 | Neo: - Age: - Region-enriched R2: 8.479/0.00000 |
3.312 | - | 0.901 | 0.721 | 0.979 | - | 0.711 | Mlig455_029074 {REF} {Length: 722} {RNA1310_65090} {RNA815_34420} | |
| 8. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 3.248 | 0.960 | - | 0.737 | 0.772 | 0.779 | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
| 9. | MligTC455_16610 | 98 | 2.05 | Mlig455_069894 | Neo: - Age: - Region-enriched R2: 5.254/0.03136 |
WSCD2 | 2.784 | 0.959 | - | - | 0.923 | 0.902 | - | Mlig455_069894 {REF} {Length: 827} {Pfam: WSC domain [PF01822.21, score=59.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=55.1, Expect=4e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=9e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
| 10. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
2.766 | 0.983 | - | - | 0.968 | 0.815 | - | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
| 11. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
2.763 | 0.966 | - | - | 0.904 | 0.893 | - | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
| 12. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 2.751 | 0.972 | - | - | 0.931 | 0.848 | - | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
| 13. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
2.731 | 0.977 | - | - | 0.915 | 0.839 | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
| 14. | MligTC455_52383 | 163 | 3.39 | Mlig455_015020 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.308/0.00258 |
ERP44 | 2.704 | - | 0.866 | 0.976 | - | 0.862 | - | Mlig455_015020 {REF} {Length: 2574} {Pfam: Thioredoxin-like domain [PF13848.8, score=106.0]; Thioredoxin [PF00085.22, score=64.2]; Calsequestrin [PF01216.19, score=19.9]} {Human: ENSG00000023318, ERP44, endoplasmic reticulum protein 44, [Score=244, Expect=1e-76]} {Mouse: ENSMUSG00000028343, Erp44, endoplasmic reticulum protein 44, [Score=251, Expect=1e-79]} {Dmel: FBgn0030734, CG9911, [Score=239, Expect=3e-75]} {Celegans: WBGene00016278, erp-44.1, [Score=238, Expect=5e-75]} {Smed: dd_Smed_v6_2276_0_1, dd_Smed_v6_2276_0_1, [Score=238, Expect=7e-75]} {RNA1509_48143} {RNA1310_14258.1} {RNA815_8957.1} |
| 15. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 2.696 | 0.950 | - | - | 0.904 | 0.842 | - | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
| 16. | MligTC455_17586 | 579 | 12.07 | Mlig455_029070 | Neo: - Age: - Region-specific R2: 3.959 Region-enriched R2: 2.423/0.00859 Regeneration-downregulated R6: -3.050 Regeneration-depleted R6: -3.050 |
2.681 | - | 0.918 | - | 0.954 | 0.809 | - | Mlig455_029070 {REF} {Length: 859} {RNA1509_53221, RNA1509_56226} {RNA1310_52775.1, RNA1509_53221, RNA1509_56226} {RNA1509_53221, RNA1509_56226, RNA815_35656} | |
| 17. | MligTC455_15883 | 95 | 1.98 | Mlig455_020080, Mlig455_040893 | Neo: - Age: - |
2.679 | 0.952 | - | - | 0.958 | 0.769 | - | Mlig455_020080 {REF} {Length: 1487} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} Mlig455_040893 {REF} {Length: 1486} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=21.0]} {RNA1310_27849} {RNA815_37376} |
|
| 18. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
2.676 | 0.863 | - | - | 0.984 | 0.829 | - | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
| 19. | MligTC455_26519 | 183 | 3.82 | Mlig455_030983, Mlig455_069440 | Neo: - Age: - |
2.674 | - | - | 0.784 | 0.988 | 0.902 | - | Mlig455_030983 {REF} {Length: 688} {RNA1509_12904} {RNA1310_62229} {RNA815_56172} Mlig455_069440 {REF} {Length: 1096} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.9]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
| 20. | MligTC455_50171 | 151 | 3.14 | Mlig455_065462 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.212 Region-enriched R2: 5.063/0.00089 Regeneration-downregulated R2: -2.783 Regeneration-depleted R2: -2.783 |
SCNN1A | 2.655 | 0.965 | - | 0.775 | 0.915 | - | - | Mlig455_065462 {REF} {Length: 3905} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=67.0, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=92.8, Expect=1e-19]} {Smed: dd_Smed_v6_16959_0_1, dd_Smed_v6_16959_0_1, [Score=275, Expect=3e-83]} {RNA1509_60030} {RNA1310_56761} {RNA815_31877.1} |
| 21. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
2.655 | 0.816 | - | - | 0.980 | 0.859 | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
| 22. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
2.636 | 0.957 | - | - | 0.941 | 0.738 | - | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
| 23. | MligTC455_05098 | 127 | 2.65 | Mlig455_009525, Mlig455_009531 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.095/0.01821 |
KCNH7 | 2.627 | 0.972 | - | - | 0.830 | 0.825 | - | Mlig455_009525 {REF} {Length: 2109} {Pfam: Ion transport protein [PF00520.33, score=111.8]; Ion channel [PF07885.18, score=46.1]; Cyclic nucleotide-binding domain [PF00027.31, score=36.3]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=29.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=528, Expect=4e-176]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=509, Expect=2e-170]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=505, Expect=9e-167]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=527, Expect=4e-175]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=510, Expect=3e-171]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=504, Expect=9e-167]} {Dmel: FBgn0003353, sei, seizure, [Score=507, Expect=2e-171]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=496, Expect=1e-169]} {Smed: dd_Smed_v6_12978_0_1, dd_Smed_v6_12978_0_1, [Score=608, Expect=0.0]} {RNA1509_56964} {RNA1310_41939} {RNA815_5858.1} Mlig455_009531 {REF} {Length: 3631} {Pfam: Ion transport protein [PF00520.33, score=110.4]; Ion channel [PF07885.18, score=45.2]; Cyclic nucleotide-binding domain [PF00027.31, score=43.3]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=619, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=597, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=596, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=617, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=602, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=596, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=591, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=579, Expect=0.0]} {Smed: dd_Smed_v6_12978_0_4, dd_Smed_v6_12978_0_4, [RH, Score=716, Expect=0.0]} {RNA1509_56964} {RNA1310_23186, RNA1509_56964} {RNA1509_56964, RNA815_5858.2} |
| 24. | MligTC455_20730 | 43 | 0.9 | Mlig455_050491, Mlig455_050492 | Neo: - Age: - |
GABBR2 | 2.627 | - | - | 0.799 | 0.984 | 0.844 | - | Mlig455_050491 {REF} {Length: 2570} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=128.2]; Receptor family ligand binding region [PF01094.30, score=119.0]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=236, Expect=1e-65]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=234, Expect=4e-65]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=250, Expect=3e-70]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=206, Expect=4e-56]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=108, Expect=2e-26]} {RNA1310_11554} {RNA815_30781} Mlig455_050492 {REF} {Length: 3107} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=130.0]; Receptor family ligand binding region [PF01094.30, score=118.1]; Phage integrase family [PF00589.24, score=28.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=233, Expect=2e-63]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=233, Expect=1e-63]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=258, Expect=2e-71]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=210, Expect=2e-56]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=118, Expect=1e-29]} {RNA1310_11554} {RNA815_30781} |
| 25. | MligTC455_11776 | 33 | 0.68 | Mlig455_048959 | Neo: - Age: - |
GABBR2 | 2.626 | - | - | 0.776 | 0.987 | 0.863 | - | Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524} |
| 26. | MligTC455_39371 | 221 | 4.6 | Mlig455_068978 | Neo: - |
ABCG4 | 2.624 | 0.967 | 0.768 | - | 0.889 | - | - | Mlig455_068978 {REF} {Length: 5136} {TRANSSPLICED} {Pfam: ABC-2 type transporter [PF01061.26, score=156.2]; ABC transporter [PF00005.29, score=100.1]; ABC-2 type transporter [PF19055.2, score=74.6]; RsgA GTPase [PF03193.18, score=25.8]; RecF/RecN/SMC N terminal domain [PF02463.21, score=24.2]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=18.8]} {Human: ENSG00000172350, ABCG4, ATP binding cassette subfamily G member 4, [RH, Score=647, Expect=0.0]; ENSG00000160179, ABCG1, ATP binding cassette subfamily G member 1, [RH, Score=641, Expect=0.0]} {Mouse: ENSMUSG00000032131, Abcg4, ATP binding cassette subfamily G member 4, [RH, Score=657, Expect=0.0]; ENSMUSG00000024030, Abcg1, ATP binding cassette subfamily G member 1, [RH, Score=637, Expect=0.0]} {Dmel: FBgn0020762, Atet, ABC transporter expressed in trachea, [RH, Score=610, Expect=0.0]} {Celegans: WBGene00015479, wht-1, ABC transporter ATP-binding protein/permease wht-1, [RH, Score=272, Expect=1e-81]} {Smed: dd_Smed_v6_4142_0_1, dd_Smed_v6_4142_0_1, [RH, Score=413, Expect=1e-139]} {RNA1509_38106} {RNA1310_4533, RNA1509_38106} {RNA1509_38106, RNA815_2836} |
| 27. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
2.616 | - | - | 0.787 | 0.984 | 0.845 | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
| 28. | MligTC455_10082 | 430 | 8.96 | Mlig455_000403, Mlig455_000471 | Neo: - Age: - Region-enriched R2: 2.917/0.00040 |
2.611 | - | 0.851 | - | 0.980 | 0.780 | - | Mlig455_000403 {REF} {Length: 747} {RNA1310_48386} {RNA815_37422} Mlig455_000471 {REF} {Length: 750} {RNA1310_48386} {RNA815_37422} |
|
| 29. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
2.61 | - | - | 0.766 | 0.978 | 0.866 | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
| 30. | MligTC455_45811 | 216 | 4.5 | Mlig455_015628 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.807/0.00004 |
2.609 | - | - | 0.775 | 0.972 | 0.862 | - | Mlig455_015628 {REF} {Length: 1061} {RNA1310_43338} {RNA815_24238} | |
| 31. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
2.608 | - | - | 0.750 | 0.991 | 0.867 | - | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
| 32. | MligTC455_53826 | 179 | 3.73 | Mlig455_013881 | Neo: - Age: - |
2.607 | - | - | 0.846 | 0.992 | 0.769 | - | Mlig455_013881 {REF} {Length: 694} {RNA1310_41119} {RNA815_15825} | |
| 33. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 2.601 | 0.955 | - | - | 0.847 | 0.799 | - | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
| 34. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
2.598 | - | - | 0.745 | 0.987 | 0.866 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
| 35. | MligTC455_10083 | 397 | 8.27 | Mlig455_000410, Mlig455_000477 | Neo: - Age: logFC(26M/2M)=1.533 Region-enriched R2: 3.033/0.00070 |
2.598 | - | 0.857 | - | 0.981 | 0.760 | - | Mlig455_000410 {REF} {Length: 1205} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} Mlig455_000477 {REF} {Length: 1206} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} |
|
| 36. | MligTC455_42391 | 1050 | 21.88 | Mlig455_010516, Mlig455_061820, Mlig455_061856, Mlig455_061864 | Neo: - Age: Down-Up-Up |
2.597 | - | 0.773 | - | 0.963 | 0.861 | - | Mlig455_010516 {REF} {Length: 729} {RNA1509_38791} {RNA1310_69853, RNA1509_38791} {RNA1509_38791, RNA815_39199} Mlig455_061820 {REF} {Length: 705} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061856 {REF} {Length: 708} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061864 {REF} {Length: 1146} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} |
|
| 37. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
2.593 | 0.979 | - | 0.786 | - | 0.828 | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
| 38. | MligTC455_15112 | 80 | 1.67 | Mlig455_038148 | Neo: - Age: - Region-enriched R2: 4.134/0.00646 |
2.581 | 0.981 | - | - | 0.872 | 0.728 | - | Mlig455_038148 {REF} {Length: 836} | |
| 39. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
2.571 | - | - | 0.742 | 0.986 | 0.843 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
| 40. | MligTC455_39370 | 144 | 2.99 | Mlig455_064116 | Neo: - Age: - |
2.571 | 0.970 | 0.774 | - | 0.827 | - | - | Mlig455_064116 {REF} {Length: 1851} {NoTransDecoderORF} {RNA1310_47097} {RNA815_28937} | |
| 41. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
2.565 | - | - | 0.733 | 0.970 | 0.862 | - | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
| 42. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
2.564 | - | 0.746 | - | 0.966 | 0.852 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
| 43. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
2.562 | - | - | 0.765 | 0.984 | 0.813 | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
| 44. | MligTC455_49222 | 1345 | 28.02 | Mlig455_054810 | Neo: - Age: logFC(26M/2M)=-0.297 Region-specific R2: 6.001 Region-enriched R2: 5.751/0.00000 |
2.562 | - | 0.823 | - | 0.983 | 0.756 | - | Mlig455_054810 {REF} {Length: 1075} {Pfam: Pancreatic hormone peptide [PF00159.20, score=94.2]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [RH, Score=44.3, Expect=7e-07]} {RNA1509_22007, RNA1509_44287, RNA1509_49301} {RNA1310_53171, RNA1509_22007, RNA1509_44287, RNA1509_49301} {RNA1509_22007, RNA1509_44287, RNA1509_49301, RNA815_34467} | |
| 45. | MligTC455_24569 | 17 | 0.35 | Mlig455_039795 | Neo: - Age: - |
CACNA2D2 | 2.551 | - | - | 0.776 | 0.959 | 0.816 | - | Mlig455_039795 {REF} {Length: 4369} {Pfam: VWA N-terminal [PF08399.13, score=79.6]; Cache domain [PF02743.20, score=54.9]; von Willebrand factor type A domain [PF13519.8, score=37.5]; von Willebrand factor type A domain [PF00092.30, score=32.3]; von Willebrand factor type A domain [PF13768.8, score=27.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=182, Expect=5e-46]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=176, Expect=3e-44]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=174, Expect=2e-43]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=182, Expect=3e-46]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=177, Expect=1e-44]; ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=176, Expect=3e-44]} {Dmel: FBgn0028863, CG4587, [Score=149, Expect=5e-36]} {Celegans: WBGene00007041, tag-180, [Score=110, Expect=4e-24]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [RH, Score=1452, Expect=0.0]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
| 46. | MligTC455_19040 | 49 | 1.03 | Mlig455_003437 | Neo: - Age: - Region-enriched R2: 6.133/0.00615 |
CAV1 | 2.549 | 0.979 | - | - | - | 0.779 | 0.791 | Mlig455_003437 {REF} {Length: 808} {Pfam: Caveolin [PF01146.19, score=118.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=101, Expect=7e-28]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=102, Expect=2e-28]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.6, Expect=9e-17]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=142, Expect=8e-45]} {RNA1509_53381} {RNA1310_97043} {RNA815_32565} |
| 47. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
2.548 | - | - | 0.725 | 0.975 | 0.848 | - | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
| 48. | MligTC455_53190 | 105 | 2.18 | Mlig455_013516 | Neo: - Age: - |
SCNN1B | 2.547 | 0.969 | - | - | 0.730 | 0.848 | - | Mlig455_013516 {REF} {Length: 2819} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=290.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=158, Expect=8e-41]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=149, Expect=1e-37]} {Dmel: FBgn0051105, ppk22, pickpocket 22, [RH, Score=60.1, Expect=3e-09]} {Celegans: WBGene00006748, unc-8, Degenerin unc-8, [RH, Score=166, Expect=2e-43]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [RH, Score=186, Expect=1e-51]} {RNA1509_18670} {RNA1310_20526} {RNA815_9932} |
| 49. | MligTC455_50806 | 257 | 5.36 | Mlig455_028471 | Neo: - Age: Up-Down-Up Region-specific R2: 3.748 Region-enriched R2: 3.524/0.00051 Regeneration-downregulated R2: -2.091 Regeneration-depleted R2: -2.091 |
2.542 | - | - | 0.780 | 0.956 | 0.806 | - | Mlig455_028471 {REF} {Length: 923} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.0]} {RNA1509_25155} {RNA1310_44043} {RNA815_21709} | |
| 50. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
2.534 | - | - | 0.718 | 0.987 | 0.829 | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
| 51. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
2.532 | - | - | 0.718 | 0.987 | 0.827 | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
| 52. | MligTC455_34365 | 761 | 15.86 | Mlig455_045898 | Neo: - |
2.526 | 0.965 | - | - | - | 0.793 | 0.768 | Mlig455_045898 {REF} {Length: 1534} {RNA1509_18388, RNA1509_36026, RNA1509_43852} {RNA1310_33460, RNA1509_18388, RNA1509_36026, RNA1509_43852} {RNA1509_18388, RNA1509_36026, RNA1509_43852, RNA815_35266} | |
| 53. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
2.518 | - | - | 0.712 | 0.983 | 0.823 | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
| 54. | MligTC455_17286 | 18 | 0.37 | Mlig455_062850, Mlig455_062932 | Neo: - Age: - |
NPFFR2, QRFPR | 2.516 | - | - | 0.787 | 0.974 | 0.755 | - | Mlig455_062850 {REF} {Length: 2774} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=136.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=17.9]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=132, Expect=1e-33]; ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=130, Expect=4e-33]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=137, Expect=9e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=138, Expect=9e-36]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} Mlig455_062932 {REF} {Length: 1463} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=135.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=29.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=19.2]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=7e-33]; ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=128, Expect=2e-32]} {Mouse: ENSMUSG00000031212, Pgr15l, G protein-coupled receptor 15-like, [Score=138, Expect=8e-36]} {Dmel: FBgn0004841, TkR86C, Tachykinin-like receptor at 86C, [Score=136, Expect=4e-35]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=95.1, Expect=4e-21]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=105, Expect=1e-24]} {RNA1310_125205} |
| 55. | MligTC455_18505 | 15 | 0.31 | Mlig455_017536 | Neo: - Age: - |
2.515 | - | - | 0.776 | 0.960 | 0.779 | - | Mlig455_017536 {REF} {Length: 2174} {RNA1310_61282} {RNA815_41334} | |
| 56. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 2.511 | - | - | 0.777 | 0.981 | 0.753 | - | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
| 57. | MligTC455_53827 | 41 | 0.85 | Mlig455_057728 | Neo: - Age: - Region-enriched R2: 6.363/0.00033 |
2.498 | - | - | 0.738 | 0.988 | 0.772 | - | Mlig455_057728 {REF} {Length: 1074} {RNA1310_41119} {RNA815_15825} | |
| 58. | MligTC455_39060 | 962 | 20.05 | Mlig455_034536, Mlig455_070441 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.435 Region-enriched R5: 1.668/0.00004 |
2.49 | 0.956 | 0.755 | - | - | 0.779 | - | Mlig455_034536 {REF} {Length: 2890} {Smed: dd_Smed_v6_10049_0_1, dd_Smed_v6_10049_0_1, [RH, Score=130, Expect=3e-32]} {RNA1509_7991} {RNA1310_1271.1} {RNA815_16754} Mlig455_070441 {REF} {Length: 2941} {Smed: dd_Smed_v6_10049_0_1, dd_Smed_v6_10049_0_1, [RH, Score=129, Expect=4e-32]} {RNA1509_7991} {RNA1310_1271.1, RNA1509_7991} {RNA1509_7991, RNA815_16754} |
|
| 59. | MligTC455_16439 | 147 | 3.07 | Mlig455_026017, Mlig455_070446 | Neo: - Age: - Region-enriched R2: 5.463/0.01159 |
SYN3 | 2.472 | 0.964 | - | 0.732 | 0.776 | - | - | Mlig455_026017 {REF} {Length: 1744} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=157.5]} {Human: ENSG00000185666, SYN3, synapsin III, [Score=169, Expect=2e-47]; ENSG00000008056, SYN1, synapsin I, [Score=167, Expect=2e-46]; ENSG00000157152, SYN2, synapsin II, [Score=165, Expect=2e-49]} {Mouse: ENSMUSG00000037217, Syn1, synapsin I, [Score=169, Expect=2e-47]; ENSMUSG00000009394, Syn2, synapsin II, [Score=168, Expect=5e-48]; ENSMUSG00000059602, Syn3, synapsin III, [Score=168, Expect=1e-47]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=169, Expect=3e-48]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=112, Expect=3e-28]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [Score=167, Expect=3e-49]} {RNA1310_44259} {RNA815_33612} Mlig455_070446 {REF} {Length: 1739} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=159.2]} {Human: ENSG00000185666, SYN3, synapsin III, [Score=169, Expect=2e-47]; ENSG00000008056, SYN1, synapsin I, [Score=168, Expect=1e-46]; ENSG00000157152, SYN2, synapsin II, [Score=164, Expect=4e-49]} {Mouse: ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=1e-47]; ENSMUSG00000059602, Syn3, synapsin III, [Score=168, Expect=2e-47]; ENSMUSG00000009394, Syn2, synapsin II, [Score=166, Expect=2e-47]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=175, Expect=2e-50]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=107, Expect=2e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [Score=173, Expect=3e-51]} {RNA1310_44259} {RNA815_33612} |
| 60. | MligTC455_45943 | 66 | 1.38 | Mlig455_012164 | Neo: - Age: Up-Up-Down |
NPR2 | 2.472 | - | - | 0.704 | 0.961 | 0.807 | - | Mlig455_012164 {REF} {Length: 4580} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=225.3]; Receptor family ligand binding region [PF01094.30, score=169.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=126.7]; Protein kinase domain [PF00069.27, score=114.0]; Heme NO binding associated [PF07701.16, score=19.2]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [RH, Score=791, Expect=0.0]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [RH, Score=629, Expect=0.0]} {Dmel: FBgn0051183, CG31183, [RH, Score=826, Expect=0.0]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [RH, Score=600, Expect=0.0]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [RH, Score=955, Expect=0.0]} {RNA1509_42903} {RNA1310_5627} {RNA815_1811} |
| 61. | MligTC455_48520 | 46 | 0.96 | Mlig455_004433 | Neo: - Age: - |
2.463 | 0.963 | - | 0.723 | 0.777 | - | - | Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009} | |
| 62. | MligTC455_38278 | 50 | 1.04 | Mlig455_014927 | Neo: - Age: - |
NOL4L | 2.462 | - | - | 0.709 | 0.968 | 0.785 | - | Mlig455_014927 {REF} {Length: 2062} {Human: ENSG00000197183, NOL4L, nucleolar protein 4 like, [RH, Score=149, Expect=3e-39]} {Mouse: ENSMUSG00000061411, Nol4l, nucleolar protein 4-like, [RH, Score=149, Expect=4e-39]} {Dmel: FBgn0283651, CG46301, [RH, Score=146, Expect=3e-37]} {Smed: dd_Smed_v6_27580_0_1, dd_Smed_v6_27580_0_1, [RH, Score=83.2, Expect=5e-17]} {RNA1310_111241} {RNA815_49535} |
| 63. | MligTC455_40781 | 153 | 3.2 | Mlig455_024109, Mlig455_063982 | Neo: - Age: - |
2.46 | - | - | 0.705 | 0.971 | 0.784 | - | Mlig455_024109 {REF} {Length: 1081} {RNA1509_16458} {RNA1310_43664.1, RNA1509_16458} {RNA1509_16458, RNA815_23166} Mlig455_063982 {REF} {Length: 3562} {RNA1509_16458} {RNA1310_30070} {RNA815_23166} |
|
| 64. | MligTC455_25922 | 42 | 0.88 | Mlig455_006651 | Neo: - Age: - |
2.458 | - | - | 0.724 | 0.994 | 0.740 | - | Mlig455_006651 {REF} {Length: 1526} {RNA1509_12380} {RNA1310_42539} {RNA815_19957} | |
| 65. | MligTC455_29118 | 467 | 9.72 | Mlig455_040411 | Neo: - Age: - Region-specific R2: 6.456 Region-enriched R2: 5.344/0.00023 |
2.456 | 0.710 | - | - | 0.954 | 0.792 | - | Mlig455_040411 {REF} {Length: 599} {TRANSSPLICED} {RNA1509_53840} {RNA1310_67192, RNA1509_53840} {RNA1509_53840, RNA815_27042} | |
| 66. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 2.453 | - | - | 0.776 | 0.965 | 0.712 | - | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
| 67. | MligTC455_25703 | 225 | 4.7 | Mlig455_017402, Mlig455_030916 | Neo: - Age: - |
2.428 | - | 0.738 | - | 0.987 | 0.703 | - | Mlig455_017402 {REF} {Length: 899} {RNA1310_52753} {RNA815_26527} Mlig455_030916 {REF} {Length: 700} {RNA1310_52753} {RNA815_26527} |
|
| 68. | MligTC455_44581 | 21 | 0.45 | Mlig455_051467, Mlig455_066697, Mlig455_066705 | Neo: - Age: - |
2.417 | - | - | 0.750 | 0.961 | 0.706 | - | Mlig455_051467 {REF} {Length: 1757} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.6]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=2e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066697 {REF} {Length: 2064} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.7]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=3e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066705 {REF} {Length: 2021} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=46.4]} {RNA1310_22174} {RNA815_24783} |
|
| 69. | MligTC455_48230 | 218 | 4.55 | Mlig455_025904 | Neo: - Age: - |
2.413 | 0.958 | - | - | 0.750 | 0.705 | - | Mlig455_025904 {REF} {Length: 3803} {Pfam: Domain of unknown function (DUF4139) [PF13598.8, score=147.7]; N-terminal domain of unknown function (DUF4140) [PF13600.8, score=63.8]} {Celegans: WBGene00016877, C52D10.3, [Score=253, Expect=5e-74]} {Smed: dd_Smed_v6_3629_0_1, dd_Smed_v6_3629_0_1, [RH, Score=449, Expect=7e-148]} {RNA1509_25634} {RNA1310_6356.1} {RNA815_11616} | |
| 70. | MligTC455_49697 | 47 | 0.97 | Mlig455_004472 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.634 Region-enriched R2: 5.369/0.00560 |
SVOP | 1.962 | 0.975 | - | - | 0.987 | - | - | Mlig455_004472 {REF} {Length: 3727} {Pfam: Major Facilitator Superfamily [PF07690.18, score=79.8]; Sugar (and other) transporter [PF00083.26, score=79.5]} {Human: ENSG00000166111, SVOP, SV2 related protein, [Score=223, Expect=8e-66]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [Score=206, Expect=1e-59]} {Dmel: FBgn0034956, CG4324, [Score=164, Expect=8e-45]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [Score=193, Expect=2e-55]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=179, Expect=1e-50]} {RNA1509_47809} {RNA1310_13019, RNA1509_47809} {RNA1509_47809, RNA815_31681} |
| 71. | MligTC455_38875 | 37 | 0.78 | Mlig455_029375, Mlig455_029415 | Neo: - Age: logFC(26M/2M)=-0.939 |
GRIK2 | 1.958 | 0.975 | - | - | 0.983 | - | - | Mlig455_029375 {REF} {Length: 3713} {Pfam: Ligand-gated ion channel [PF00060.28, score=88.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=58.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=34.5]; Receptor family ligand binding region [PF01094.30, score=20.4]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=136, Expect=2e-32]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=137, Expect=9e-33]} {Dmel: FBgn0038837, CG3822, [Score=150, Expect=4e-37]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=242, Expect=3e-72]} {RNA1310_67049} {RNA815_49856} Mlig455_029415 {REF} {Length: 2520} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=25.5]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=73.9, Expect=5e-14]} {RNA1310_74947} {RNA815_49856} |
| 72. | MligTC455_10771 | 22 | 0.45 | Mlig455_020287 | Neo: - Age: - |
LCK | 1.931 | - | - | - | 0.973 | 0.958 | - | Mlig455_020287 {REF} {Length: 6454} {Pfam: Variant SH3 domain [PF14604.8, score=39.7]; SH3 domain [PF00018.30, score=38.4]; SH2 domain [PF00017.26, score=27.6]; Variant SH3 domain [PF07653.19, score=20.7]} {Human: ENSG00000182866, LCK, LCK proto-oncogene, Src family tyrosine kinase, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000000409, Lck, lymphocyte protein tyrosine kinase, [Score=95.1, Expect=2e-20]} {Dmel: FBgn0262733, Src64B, Src oncogene at 64B, [Score=81.6, Expect=3e-16]} {Smed: dd_Smed_v6_3147_0_1, dd_Smed_v6_3147_0_1, [Score=103, Expect=1e-23]} {RNA1509_5045} {RNA1310_667.1} {RNA815_350} |
| 73. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
1.925 | 0.959 | - | - | 0.966 | - | - | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
| 74. | MligTC455_47712 | 80 | 1.66 | Mlig455_044833 | Neo: - Age: - |
1.913 | 0.955 | - | - | 0.958 | - | - | Mlig455_044833 {REF} {Length: 564} {RNA1509_55855} {RNA1310_87612} {RNA815_50831} | |
| 75. | MligTC455_35290 | 14 | 0.29 | Mlig455_015751, Mlig455_049473 | Neo: - Age: - |
1.901 | - | - | - | 0.968 | 0.933 | - | Mlig455_015751 {REF} {Length: 1661} {RNA1509_27214} {RNA1310_93069} {RNA815_21353} Mlig455_049473 {REF} {Length: 733} {RNA1310_93069} |
|
| 76. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.896 | - | - | - | 0.987 | 0.909 | - | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
| 77. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 1.887 | - | - | - | 0.982 | 0.905 | - | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
| 78. | MligTC455_22077 | 58 | 1.2 | Mlig455_041277 | Neo: - Age: - |
1.882 | - | - | - | 0.984 | 0.898 | - | Mlig455_041277 {REF} {Length: 1351} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=30.4]} {RNA1310_27422} {RNA815_33833} | |
| 79. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
1.878 | - | - | - | 0.983 | 0.895 | - | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
| 80. | MligTC455_40850 | 7 | 0.14 | Mlig455_042076 | Neo: - Age: logFC(26M/2M)=0.689 |
1.871 | - | - | - | 0.961 | 0.910 | - | Mlig455_042076 {REF} {Length: 3408} {Pfam: REJ domain [PF02010.17, score=59.0]; PKD domain [PF18911.2, score=26.8]; PKD domain [PF00801.22, score=26.0]} {RNA1509_8046} {RNA1310_93} {RNA815_2228} | |
| 81. | MligTC455_07826 | 23 | 0.48 | Mlig455_056551 | Neo: - Age: - |
1.863 | - | - | - | 0.982 | 0.881 | - | Mlig455_056551 {REF} {Length: 3263} {Pfam: PH domain [PF00169.31, score=23.0]} {RNA1310_46895.1} {RNA815_27323} | |
| 82. | MligTC455_19583 | 95 | 1.97 | Mlig455_010583, Mlig455_010602 | Neo: - Age: - Region-enriched R2: 6.442/0.00383 |
1.862 | - | - | - | 0.959 | 0.903 | - | Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135} Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135} |
|
| 83. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.86 | - | - | - | 0.981 | 0.879 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
| 84. | MligTC455_17735 | 271 | 5.64 | Mlig455_017593, Mlig455_058810, Mlig455_058862 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.542 Region-enriched R2: 2.633/0.02130 |
1.857 | - | - | - | 0.986 | 0.871 | - | Mlig455_017593 {REF} {Length: 676} {TRANSSPLICED} {RNA1310_42115} {RNA815_33119} Mlig455_058810 {REF} {Length: 1574} {RNA1509_8571} {RNA1310_42115} {RNA815_33119} Mlig455_058862 {REF} {Length: 834} {TRANSSPLICED} {RNA1310_42115} {RNA815_33119} |
|
| 85. | MligTC455_18748 | 104 | 2.17 | Mlig455_024985, Mlig455_024999 | Neo: - Age: - Region-enriched R2: 6.002/0.00016 |
GRIK4 | 1.854 | - | - | - | 0.987 | 0.867 | - | Mlig455_024985 {REF} {Length: 1514} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_47299} {RNA815_38321} Mlig455_024999 {REF} {Length: 3567} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_7578, RNA1509_35538} {RNA1509_35538, RNA815_4987} |
| 86. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
1.852 | - | - | - | 0.979 | 0.873 | - | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
| 87. | MligTC455_26356 | 62 | 1.3 | Mlig455_042551 | Neo: - |
GRIK2 | 1.847 | - | - | - | 0.984 | 0.863 | - | Mlig455_042551 {REF} {Length: 2917} {Pfam: Ligand-gated ion channel [PF00060.28, score=82.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=60.7]; Receptor family ligand binding region [PF01094.30, score=32.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=144, Expect=9e-35]; ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=141, Expect=7e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=142, Expect=2e-34]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=119, Expect=3e-27]} {Celegans: WBGene00001616, glr-5, GLutamate Receptor family (AMPA), [Score=123, Expect=2e-28]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=247, Expect=4e-74]} {RNA1310_21865} {RNA815_26044} |
| 88. | MligTC455_17895 | 389 | 8.1 | Mlig455_060774 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.268 Region-specific R2: 7.424 Region-enriched R2: 6.488/0.00062 Regeneration-downregulated R2: -4.133 Regeneration-depleted R2: -4.133 |
1.846 | - | - | - | 0.987 | 0.859 | - | Mlig455_060774 {REF} {Length: 1670} {RNA1509_34403} {RNA1310_35901, RNA1509_34403} {RNA1509_34403, RNA815_35590} | |
| 89. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 1.846 | - | - | - | 0.983 | 0.863 | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
| 90. | MligTC455_29168 | 95 | 1.99 | Mlig455_001005 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.838/0.04040 |
DNAH5 | 1.845 | 0.960 | - | - | - | 0.885 | - | Mlig455_001005 {REF} {Length: 14882} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=578.4]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=466.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=431.3]; Dynein heavy chain C-terminal domain [PF18199.3, score=314.7]; P-loop containing dynein motor region D4 [PF12780.9, score=302.4]; ATP-binding dynein motor region [PF12781.9, score=290.8]; P-loop containing dynein motor region [PF12775.9, score=229.7]; Dynein heavy chain AAA lid domain [PF18198.3, score=179.1]; Microtubule-binding stalk of dynein motor [PF12777.9, score=143.2]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=121.5]; AAA domain (dynein-related subfamily) [PF07728.16, score=75.6]; Dynein heavy chain AAA lid domain [PF17852.3, score=70.7]; AAA+ lid domain [PF17857.3, score=60.9]; AAA ATPase domain [PF13191.8, score=22.0]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.4]; P-loop containing region of AAA domain [PF13555.8, score=20.3]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [RH, Score=6260, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [RH, Score=6234, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [RH, Score=5093, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=1290, Expect=0.0]} {Smed: dd_Smed_v6_4569_0_1, dd_Smed_v6_4569_0_1, [RH, Score=6941, Expect=0.0]} {RNA1509_51275} {RNA1310_408, RNA1509_51275} {RNA1509_51275, RNA815_44.1} |
| 91. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 1.844 | - | - | - | 0.967 | 0.877 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
| 92. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
1.842 | - | - | - | 0.986 | 0.856 | - | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
| 93. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
1.842 | - | - | - | 0.981 | 0.861 | - | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
| 94. | MligTC455_19059 | 32 | 0.66 | Mlig455_001467 | Neo: - Age: - |
INSC | 1.842 | - | - | - | 0.951 | 0.891 | - | Mlig455_001467 {REF} {Length: 2215} {Pfam: Protein inscuteable C-terminal [PF19427.1, score=199.4]} {Human: ENSG00000188487, INSC, INSC, spindle orientation adaptor protein, [Score=183, Expect=1e-50]} {Mouse: ENSMUSG00000048782, Insc, INSC spindle orientation adaptor protein, [Score=180, Expect=9e-50]} {Smed: dd_Smed_v6_13059_0_1, dd_Smed_v6_13059_0_1, [Score=118, Expect=5e-28]} {RNA1310_37397} |
| 95. | MligTC455_50665 | 48 | 0.99 | Mlig455_032812 | Neo: - Age: - |
1.842 | 0.980 | - | - | - | 0.862 | - | Mlig455_032812 {REF} {Length: 1550} {Pfam: Glycine rich protein [PF12810.9, score=23.7]} {RNA1310_48243.1} {RNA815_30313.2} | |
| 96. | MligTC455_31345 | 102 | 2.12 | Mlig455_004435, Mlig455_004447 | Neo: - Age: - |
RTL1 | 1.841 | - | - | - | 0.981 | 0.860 | - | Mlig455_004435 {REF} {Length: 551} {RNA1310_70973} {RNA815_36768} Mlig455_004447 {REF} {Length: 2743} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=93.3]; Integrase zinc binding domain [PF17921.3, score=77.6]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=45.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=75.9, Expect=2e-13]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=255, Expect=1e-71]} {RNA1509_33330} {RNA1310_5975.2} {RNA815_11487} |
| 97. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
1.84 | - | - | - | 0.980 | 0.860 | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
| 98. | MligTC455_48604 | 173 | 3.6 | Mlig455_031074 | Neo: - |
1.84 | - | - | - | 0.987 | 0.853 | - | Mlig455_031074 {REF} {Length: 652} {RNA1310_66509} | |
| 99. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.838 | - | - | - | 0.978 | 0.860 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
| 100. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 1.835 | - | - | - | 0.978 | 0.857 | - | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
There are 361 more genes with r >= 0.95